Bcl6 is expressed in neuroblastoma: tumor cell type-specific expression predicts outcome.
Neuroblastoma (NB) is the most common extracranial solid neoplasm of infancy and childhood. Whereas most low-risk patients do well, children with high-risk tumors often fail intensive treatment. Identification of novel biomarkers is critical to improve prognostication, tailor therapy, and develop new therapeutic targets. Differential RNA-level expression between tumor cells with neuroblastic (N-type) and Schwannian stromal (S-type) phenotypes was used to identify genes of potential interest based on tumor cell type-specific regulation. Gene expression microarray analysis revealed marked differences between N-type and S-type cells in their levels of BCL6 messenger RNA, a transcriptional regulator overexpressed in a variety of hematopoietic malignancies. S-type cells express higher levels of Bcl6 RNA and protein than N-type, and protein levels are significantly limited by proteasome function. An NB tumor tissue microarray linked to clinicopathologic data was immunohistochemically stained to measure Bcl6 protein levels. Bcl6 was detected in both the neuroblastic and Schwannian stromal regions, as distinguished histologically, and correlated with outcome. We found that expression in neuroblastic regions differentiates outcomes, in that Bcl6 expression in neuroblastic regions is associated with increased time to relapse and increased overall survival compared with absent expression in neuroblastic regions, regardless of Schwannian stromal expression. Thus, our findings suggest that Bcl6 may be useful as a prognostic marker and might represent a potential therapeutic target for high-risk NB.
Chamdin
Aghiad
A
Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA.
Jarzembowski
Jason A
JA
Subramanian
Chitra
C
Kuick
Rork
R
Lee
Julia Shin-Jung
JS
Kwok
Roland Ps
RP
Castle
Valerie P
VP
Opipari
Anthony W
AW
Blood. 1995 Jul 1;86(1):28-37
7795234
Cancer Res. 1989 Jan 1;49(1):219-25
2535691
Am J Clin Pathol. 2004 Jan;121(1):34-42
14750238
Am J Pathol. 2001 Oct;159(4):1231-8
11583950
OMICS. 2003 Fall;7(3):235-52
14583114
J Clin Oncol. 2000 Jul;18(13):2582-92
10893290
Blood. 2003 Jan 15;101(2):706-10
12393409
Nat Immunol. 2005 Oct;6(10):1054-60
16142238
Cancer Cell. 2006 Jun;9(6):435-43
16766263
Oncogene. 1996 Jun 6;12(11):2331-42
8649773
J Clin Oncol. 1999 Jul;17(7):2264-79
10561284
Nat Immunol. 2007 Jul;8(7):705-14
17558410
Cancer Cell. 2005 May;7(5):445-55
15894265
Pediatr Blood Cancer. 2007 Mar;48(3):311-7
16609945
Curr Opin Pediatr. 2005 Feb;17(1):7-13
15659956
Pathol Int. 1997 Sep;47(9):600-7
9311010
J Clin Oncol. 2005 Dec 1;23(34):8819-27
16314642
Carcinogenesis. 2004 Oct;25(10):1839-46
15155532
Genes Chromosomes Cancer. 2007 Oct;46(10):936-49
17647283
Oncogene. 2003 Aug 28;22(36):5572-8
12944904
J Immunol. 2002 Aug 15;169(4):1922-9
12165517
Nature. 2004 Dec 2;432(7017):635-9
15577913
Nat Immunol. 2007 Oct;8(10):1132-9
17828269
Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12520-4
8618933
Cancer Res. 1999 Sep 1;59(17):4392-9
10485488
Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):6947-52
8692924
N Engl J Med. 1996 Jun 6;334(23):1505-11
8618605
Clin Cancer Res. 2003 Dec 15;9(17):6316-25
14695130
Genes Dev. 1998 Jul 1;12(13):1953-61
9649500
Cancer Res. 2001 Sep 15;61(18):6892-8
11559566
Blood. 2001 Aug 15;98(4):945-51
11493437
Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4842-7
15778293
Nat Med. 2003 Jul;9(7):969-73
12819780
Cell Growth Differ. 1995 Apr;6(4):449-56
7794812
J Biol Chem. 2001 Dec 28;276(52):48921-9
11679590
Blood. 1995 Jul 1;86(1):45-53
7795255
BMC Bioinformatics. 2005 Feb 10;6:26
15705192
Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11816-21
9751748
Biochim Biophys Acta. 2006 Oct;1763(10):1000-10
16979248
Pathol Biol (Paris). 2007 Feb;55(1):73-83
16815642
Nat Rev Cancer. 2003 Mar;3(3):203-16
12612655
Ann Oncol. 1999 Jun;10(6):715-21
10442195
Cancer. 1999 Jul 15;86(2):364-72
10421273
Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):15018-23
12407182
Cancer Res. 1987 Mar 1;47(5):1383-9
3028608
N Engl J Med. 2005 Nov 24;353(21):2243-53
16306521
Lancet. 2007 Jun 23;369(9579):2106-20
17586306
Oncogene. 2006 Apr 6;25(15):2223-33
16331266
Cancer Res. 1987 Dec 15;47(24 Pt 1):6505-10
2445473
Cancer. 1999 Jul 15;86(2):349-63
10421272
Oncogene. 1995 Dec 21;11(12):2689-97
8545127
Clin Cancer Res. 2003 Mar;9(3):1063-9
12631608
Cancer. 2008 Jan 1;112(1):151-6
17999414
Am J Med Genet. 1994 Oct 15;53(1):24-8
7802031
Cancer Lett. 2003 Jul 18;197(1-2):35-9
12880957
Blood. 2006 Feb 15;107(4):1599-607
16249378
Exp Cell Res. 2004 May 1;295(2):469-87
15093745